Conditions: Renal Cell Carcinoma
Keywords: cancer tumour advanced cancer Metastatic renal cell carcinoma kidney cancer RECENTIN
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 105
Healthy volunteers: no

Brief summary:
Cediranib is being tested to assess its effectiveness on the growth of kidney cancer tumours and also how well it is tolerated.

Detailed description:

Arms:
arm 1: Cediranib placebo arm 2: Cediranib

Interventions: intervention 1: Cediranib intervention 2: Cediranib Placebo
Intervention descriptions: intervention 1: 45 mg oral tablet intervention 2: oral tablet

Protocol document: